Gonadotropin releasing hormone (GnRH) neurons originate in or near the olfactory placode and migrate into the forebrain during embryogenesis. Disruption of GnRH neuronal migration or production results in abnormal reproductive function in humans. Axl is a member of the TAM family of receptor tyrosine kinases (Tyro3, Axl and Mer) whose major ligand is growth arrest specific gene 6 (Gas6). Gas6 activation of Axl and Tyro3 promotes GnRH neuronal cell migration and survival. Axl/Tyro3 null mice demonstrate delayed first estrus, abnormal estrus cyclicity and prolonged proestrus. During embryogenesis, there is a decreased number and mistargeting of immunoreactive GnRH neurons, confirming the central role of Axl and Tyro3 in GnRH neuronal development and function. We show new preliminary data that human subjects with Kallmann Syndrome (KS) and normosmic idiopathic hypogonadotropic hypogonadism (nIHH) harbor mutations in Axl, supporting the importance of understanding the role of the TAM system in reproduction. In this application:
Aim 1 will determine the ligand dependence of the TAM family effects on reproduction and GnRH neuron survival and migration in vivo. Comparison of Axl/Tyro3 null and Gas6 null mice will define the relative importance of the TAM member and/or ligand during both early GnRH neuron development and their impact on the timing of sexual maturation and reproductive competence.
Aim 2 will delineate the neuronal-specific signaling pathways by which Axl or Tyro3 promote GnRH neuronal survival and migration. Studies in GnRH neuronal cells outlined the importance of PI3K/Akt and ERK signaling for survival, and of p38MAPK for migration downstream of Axl and Tyro3. An ex vivo model of embryonic brain slices from control, Axl/Tyro3 null and Gas6 null mice in the presence or absence of specific inhibitors of PI3K, ERK and/or p38MAPK will dissect the role of each in neuronal survival and migration. Oligonucleotide microarrays will identify the neuronal specific components downstream of TAM signaling that promote GnRH survival and migration, which then will be confirmed in the ex vivo brain slice model.
Aim 3 will define the functional significance of novel TAM mutations detected in KS and nIHH subjects. We have identified the first AXL mutations in subjects with KS and nIHH, not found in SNP databases or community controls. Functional analysis of the effects of these mutations on TAM signaling and survival and migration in GnRH neuronal cells will be performed. Screening for mutations in other TAM family members and testing the functional impact of these changes will clarify the range of human TAM mutations leading to reproductive disorders. Mutations in components of TAM signaling pathways may contribute to reproductive disorders in humans, justifying the importance of further dissection of the function of this novel system during GnRH neuron development.

Public Health Relevance

Our goals are to identify and characterize novel factors involved in Gonadotropin releasing hormone (GnRH) neuron development, a process that is required for normal reproductive function in mice and humans. Studies will define the roles of Axl and Tyro3 receptor tyrosine kinases and their common ligand, growth arrest specific gene-6 (Gas6), in GnRH neuron migration and survival during embryogenesis and postnatally. Exciting new data have identified novel AXL mutations in patients with Kalmann Syndrome and normosmic idiopathic hypogonadotropic hypogonadism, suggesting the importance of this system in human reproductive biology and justifying further analysis of this system to expand our understanding of GnRH neuron development and function.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
2R01HD031191-14A2
Application #
7781948
Study Section
Integrative and Clinical Endocrinology and Reproduction Study Section (ICER)
Program Officer
Lamar, Charisee A
Project Start
1995-07-01
Project End
2013-01-31
Budget Start
2010-09-01
Budget End
2013-01-31
Support Year
14
Fiscal Year
2010
Total Cost
$377,200
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Salian-Mehta, Smita; Xu, Mei; McKinsey, Timothy A et al. (2015) Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement. J Biol Chem 290:14045-56
Salian-Mehta, Smita; Xu, Mei; Pierce, Angela et al. (2014) Loss of Growth arrest specific gene 6 (Gas6) results in altered GnRH neuron migration, delayed vaginal opening and sexual maturation in mice. Mol Cell Endocrinol 393:164-70
Salian-Mehta, S; Xu, M; Knox, A J et al. (2014) Functional consequences of AXL sequence variants in hypogonadotropic hypogonadism. J Clin Endocrinol Metab 99:1452-60
Salian-Mehta, Smita; Xu, Mei; Wierman, Margaret E (2013) AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival. Mol Cell Endocrinol 374:92-100
Wierman, Margaret E; Xu, Mei; Pierce, A et al. (2012) Extracellular signal-regulated kinase 1 and 2 are not required for GnRH neuron development and normal female reproductive axis function in mice. Neuroendocrinology 95:289-96
Rothman, Micol S; Carlson, Nichole E; Xu, Mei et al. (2011) Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids 76:177-82
Pierce, Angela; Xu, Mei; Bliesner, Brian et al. (2011) Hypothalamic but not pituitary or ovarian defects underlie the reproductive abnormalities in Axl/Tyro3 null mice. Mol Cell Endocrinol 339:151-8
Wierman, Margaret E; Kiseljak-Vassiliades, Katja; Tobet, Stuart (2011) Gonadotropin-releasing hormone (GnRH) neuron migration: initiation, maintenance and cessation as critical steps to ensure normal reproductive function. Front Neuroendocrinol 32:43-52